Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03708276 · ClinicalTrials.gov registry record · NA

My MS Toolkit: a Symptom Self-management Program for Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03708276: Completed NA study of Multiple Sclerosis, sponsored by University of Michigan.

NCT03708276 is a NA study of Multiple Sclerosis that has completed, run by University of Michigan. The registered enrollment target is 20 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03708276, a NA study of Multiple Sclerosis, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

My MS Toolkit is a web-based symptom self-management program for persons with multiple sclerosis. This study is evaluating various aspects of My MS Toolkit and how it impacts symptom self-management in multiple sclerosis. The research team believe that the toolkit will be feasible, acceptable, and beneficial to participants.

Primary Outcome

Assessed by the Patient Satisfaction Evaluation Scale, 12 question scale where each response score ranges from 4 to 1 and the total score ranges from 48 to 12. Higher scores indicate increased satisfaction.

Conditions Studied

Multiple Sclerosis

Interventions

  • OTHER My MS Toolkit

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2019-02-26
Est. Completion 2019-09-25
Phase NA
University of Michigan

1,327 total trials

What the finished NCT03708276 record still lists

NCT03708276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which My MS Toolkit is the first listed.

NCT03708276 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT03708276 about?

NCT03708276 is a clinical study titled "My MS Toolkit: a Symptom Self-management Program for Multiple Sclerosis". My MS Toolkit is a web-based symptom self-management program for persons with multiple sclerosis. This study is evaluating various aspects of My MS Toolkit and how it impacts symptom self-management in multiple sclerosis. The research team believe that the toolkit will be feasible, acceptable, and ...

What is the current status of trial NCT03708276?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-02-26. Estimated completion is 2019-09-25.

What conditions does trial NCT03708276 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT03708276?

The interventions under investigation include: My MS Toolkit (OTHER).

Who is sponsoring clinical trial NCT03708276?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03708276 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03708276's enrollment target sits among peer trials

20 262nd of 315 higher than 41 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03708276, the US trial registry maintained by the National Library of Medicine. NCT03708276 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.